Investigación metabólica

Metabolic research peptides include GLP-1 receptor agonists and multi-pathway compounds studied for glucose regulation, appetite signaling, and systemic energy metabolism. This category focuses on incretin-based analogues used in metabolic and endocrine research models.

Key compounds in this category include Semaglutide, Tirzepatide, and Retatrutide, representing single, dual, and triple agonist approaches to metabolic pathway investigation. Semaglutida is a long-acting GLP-1 receptor agonist, while Tirzepatida activates both GLP-1 and GIP receptors. Retatrutida extends this mechanism further by engaging GLP-1, GIP, and glucagon receptors.

Explore Retatrutida, Tirzepatida, y Semaglutida, or browse related categories such as secretagogos de la hormona del crecimiento for complementary research compounds.

All products are supplied in lyophilized form and are intended for laboratory and analytical research purposes only.

For a detailed comparison of GLP-1, dual, and triple agonists, see our complete Guía de investigación metabólica de GLP-1.